Department of Pharmacy Practice, Nesbitt School of Pharmacy, Wilkes University, 84 W. South Street, Wilkes-Barre, PA 18766, USA.
J Am Pharm Assoc (2003). 2010 Jan-Feb;50(1):32-6. doi: 10.1331/JAPhA.2010.08104.
To implement a comprehensive service to screen for metabolic syndrome, assess the prevalence of metabolic syndrome, determine the 10-year risk of developing coronary heart disease (CHD), and measure the effectiveness of patient education on lifestyle modifications.
Cross-sectional study.
Community pharmacy in Pennsylvania between February 2006 and August 2007.
239 patients 18 years of age or older with no history of CHD.
Participating patients were screened for metabolic syndrome, Framingham risk assessment, and medication use. Test results were discussed and patients were educated on metabolic syndrome and lifestyle recommendations. A follow-up survey was administered.
Prevalence of metabolic syndrome in the study population, Framingham risk assessment of those with metabolic syndrome, proportion of patients with self-reported lifestyle modifications.
The prevalence of metabolic syndrome in our study population was 36%. The Framingham risk assessment of patients with metabolic syndrome and no known history of diabetes revealed that 65.3% were at low risk, 26.4% were at moderate risk, and 8.3% were at high risk for CHD. Of the study population with no known history of prediabetes or diabetes, 26% had an abnormal glucose reading. Of those with metabolic syndrome, 87% self-reported a lifestyle modification in the area of diet, exercise, or weight loss in the following 3- to 6-month follow-up period.
Pharmacists have an important role in screening patients for risk factors associated with metabolic syndrome. By providing education on lifestyle modifications, pharmacists can increase the likelihood that patients with metabolic syndrome implement lifestyle changes. A metabolic syndrome screening and education program can be successfully implemented in a community pharmacy setting.
实施一项综合服务，以筛查代谢综合征，评估代谢综合征的患病率，确定 10 年内患冠心病（CHD）的风险，并衡量患者教育对生活方式改变的效果。
横断面研究。
宾夕法尼亚州的社区药房，时间为 2006 年 2 月至 2007 年 8 月。
239 名年龄在 18 岁或以上且无 CHD 病史的患者。
参与患者接受代谢综合征筛查、弗雷明汉风险评估和药物使用情况。测试结果进行讨论，并对代谢综合征和生活方式建议对患者进行教育。随后进行了一项随访调查。
研究人群中代谢综合征的患病率、代谢综合征患者的弗雷明汉风险评估、报告生活方式改变的患者比例。
在我们的研究人群中，代谢综合征的患病率为 36%。对无已知糖尿病史的代谢综合征患者进行弗雷明汉风险评估显示，65.3%的患者处于低风险，26.4%处于中风险，8.3%处于高风险。在无已知糖尿病前期或糖尿病史的研究人群中，有 26%的患者血糖读数异常。在患有代谢综合征的患者中，87%在接下来的 3 至 6 个月随访期间报告在饮食、运动或减肥方面进行了生活方式改变。
药剂师在筛查与代谢综合征相关的危险因素方面发挥着重要作用。通过提供生活方式改变的教育，药剂师可以增加代谢综合征患者实施生活方式改变的可能性。代谢综合征筛查和教育计划可以在社区药房环境中成功实施。
